ENO1 and lung carcinoma: The functional importance of sENO1 in tumor progression was further validated by the ability of a function-inhibiting anti-ENO1 antibody, which suppresses cell-associated plasminogen activation and matrix metalloproteinase activation and thereby inhibits matrix degradation and cell invasion, to inhibit tumor metastasis in various animal models of lung cancer and PDAC (38, 40).